Abstract:Objectives: To develop a new digital biomarker based on the convolutional neural network (CNN) analysis of primary tumor tissue, hence predicting lymph nodes (LNs) status in patients with early-stage cervical squamous cell carcinoma (CSCC). Methods: A total of 406 CSCC patients who underwent radical surgery between 2006 and 2014 were randomly selected, with their LNs status and hematoxylin-eosin (HE) stained primary tumor slides reviewed and confirmed by pathologists. Regions of interest (ROIs) were delineated by our pathology team. Slides were randomly divided into training, validation, and testing sets. With all Images preprocessed into patches, a CNN was trained to classify patches as LNs positive or negative. The CNN was further tested on a third independent population of 106 patients from The Cancer Genome Atlas (TCGA) database. Results: The cases included in the training set, validation set, and test set were 286, 60, and 60, respectively. Our classifier achieved an AUC of 0.86 (95% CI: 0.82-0.89) in cross-validation of slide-level LN status, 0.81 (95% CI: 0.77-0.86) on the test set, and 0.75 (95% CI: 0.71-0.82) on TCGA test set. For patients with positive LN, the digital signatures demonstrated good discrimination between patients with only pelvic LNs positive and patients with both pelvic and para-aortic LNs positive. The best performance model achieved an AUC of 0.91 (95% CI: 0.86-0.95) in the validation cohort and 0.87 (95% CI: 0.81-0.92) in the test cohort. Objectives: To develop a new digital biomarker based on the convolutional neural network (CNN) analysis of primary tumor tissue, hence predicting lymph nodes (LNs) status in patients with early-stage cervical squamous cell carcinoma (CSCC). Methods: A total of 406 CSCC patients who underwent radical surgery between 2006 and 2014 were randomly selected, with their LNs status and hematoxylin-eosin (HE) stained primary tumor slides reviewed and confirmed by pathologists. Regions of interest (ROIs) were delineated by our pathology team. Slides were randomly divided into training, validation, and testing sets. With all Images preprocessed into patches, a CNN was trained to classify patches as LNs positive or negative. The CNN was further tested on a third independent population of 106 patients from The Cancer Genome Atlas (TCGA) database. Results: The cases included in the training set, validation set, and test set were 286, 60, and 60, respectively. Our classifier achieved an AUC of 0.86 (95% CI: 0.82-0.89) in cross-validation of slide-level LN status, 0.81 (95% CI: 0.77-0.86) on the test set, and 0.75 (95% CI: 0.71-0.82) on TCGA test set. For patients with positive LN, the digital signatures demonstrated good discrimination between patients with only pelvic LNs positive and patients with both pelvic and para-aortic LNs positive. The best performance model achieved an AUC of 0.91 (95% CI: 0.86-0.95) in the validation cohort and 0.87 (95% CI: 0.81-0.92) in the test cohort.

Predicting cancer content in tiles of lung squamous cell carcinoma tumours with validation against pathologist labels

010 Enhanced outcome prediction in cutaneous squamous cell carcinoma using deep-learning and computational histopathology (cSCCnet)

Evaluation of a Deep Learning Model for Metastatic Squamous Cell Carcinoma Prediction From Whole Slide Images

Deep learning infers clinically relevant protein levels and drug response in breast cancer from unannotated pathology images

A digital pathology AI model to predict immune-oncology biomarker status and pembrolizumab response in a real-world cohort of patients with colorectal and breast cancer.

Accurate and reproducible invasive breast cancer detection in whole-slide images: A Deep Learning approach for quantifying tumor extent

Lung Cancer Diagnosis on Virtual Histologically Stained Tissue Using Weakly Supervised Learning

Predicting Tumor Mutational Burden From Lung Adenocarcinoma Histopathological Images Using Deep Learning

Whole slide image-based weakly supervised deep learning for predicting major pathological response in non-small cell lung cancer following neoadjuvant chemoimmunotherapy: a multicenter, retrospective, cohort study

Computer-aided Detection of Squamous Carcinoma of the Cervix in Whole Slide Images

Predicting Lymph Node Status Based on Deep Learning on Histopathological Images from Primary Tumor of Early-Stage Cervical Squamous Cell Carcinoma (080)

Deep learning-based survival prediction for multiple cancer types using histopathology images

Cancer drug sensitivity prediction from routine histology images

Machine learning enabled prediction of digital biomarkers from whole slide histopathology images

Prediction of Breast Cancer Recurrence Using a Deep Convolutional Neural Network Without Region-of-Interest Labeling

Multiresolution Application of Artificial Intelligence in Digital Pathology for Prediction of Positive Lymph Nodes From Primary Tumors in Bladder Cancer.

A deep learning approach for predicting visceral pleural invasion in cT1 lung adenocarcinoma

Classification and mutation prediction from non–small cell lung cancer histopathology images using deep learning

Predicting the Tumor Microenvironment Composition and Immunotherapy Response in Non-Small Cell Lung Cancer from Digital Histopathology Images

Prediction of Tumor-Associated Macrophages and Immunotherapy Benefits Using Weakly Supervised Contrastive Learning in Breast Cancer Pathology Images

Predicting tumor mutation burden and VHL mutation from renal cancer pathology slides with self‐supervised deep learning